Optimization of isolation, expansion, and differentiation of canine intestinal organoids

This study establishes an optimized protocol for isolating, expanding, and differentiating canine intestinal organoids from the duodenum and colon, demonstrating that 100 nM PGE2 enhances growth and a two-phase differentiation approach yields functional, marker-positive models suitable for future disease research and translational applications despite a limited sample size.

The Gist

Imagine you have a tiny, living factory inside your gut. This factory is made of stem cells—blank slates that can turn into any type of cell your intestine needs, like the ones that absorb nutrients or the ones that produce mucus to protect your gut lining.

For a long time, scientists have been able to build these "mini-factories" (called organoids) for mice and humans. But dogs? They've been a bit of a mystery. Since dogs get many of the same stomach and gut diseases as humans (like inflammatory bowel disease), having a working dog model would be a huge breakthrough for veterinary medicine and human health.

This paper is the story of how a team of scientists finally figured out how to build, grow, and train these canine intestinal mini-factories.

Here is the breakdown of their journey, using some everyday analogies:

1. The Challenge: Finding the Right "Soil" and "Fertilizer"

Think of the intestinal stem cells as seeds. To make them grow into a full plant (an organoid), you need the right soil and the right fertilizer.

• The Soil: The scientists used a gel called Matrigel. Think of this as a 3D sponge or a soft bed that holds the seeds in place, mimicking the natural environment of the gut.
• The Fertilizer: They needed a special cocktail of growth factors. The big discovery here was a specific ingredient called PGE2.
  • The Analogy: Imagine you are trying to grow a garden. You try different amounts of fertilizer. Too little, and the plants are tiny. Too much, and they burn. The scientists found that adding a specific dose of PGE2 (100 nanomolar) was like finding the "Goldilocks" fertilizer. It made the dog intestinal seeds sprout faster and grow much bigger than without it.

2. The Two-Phase Training Program: "School" vs. "Work"

Once the organoids were growing big and strong, the scientists wanted to see if they could turn them into specific types of cells (like the ones that digest food or the ones that fight bacteria). They used a two-step training program:

• Phase 1: The "Patterning" Phase (The School):
  They moved the organoids into a new medium (Pattern Medium). Think of this as sending the cells to school. They are learning their roles. The scientists added a special teacher named IL-22 (specifically for the small intestine part) to help the cells learn how to become protective cells, similar to how Paneth cells work in humans.
• Phase 2: The "Differentiation" Phase (The Job):
  Then, they moved them to the "Differentiation Medium." This is like sending the students out to work in the real world. The goal was to see if they could mature into fully functional cells that act just like the real gut lining.

3. The Results: Did the Students Pass the Test?

The scientists ran several tests to see if their "mini-dog-guts" were working correctly.

• The Gene Test (The Report Card): They checked the cells' DNA to see if they were making the right proteins.
  • The Result: While the sample size was small (only two dogs, which is like grading a class of two students), the trends were promising. The "small intestine" organoids and "colon" organoids reacted differently to the training, just like real dog guts do. The small intestine cells seemed to learn their lessons faster in the "school" phase, while the colon cells showed different strengths in the "work" phase.
• The Microscope Test (The Visual Inspection): They looked at the cells under a microscope.
  • The Result: The cells looked healthy. They had the right shapes and were holding hands (sticking together) properly. Interestingly, when the cells were in the "work" phase, they stopped dividing as much and started acting more like mature, finished products.
• The "Swelling" Test (The Functional Check): This was the coolest test. They added a chemical called forskolin to the organoids.
  • The Analogy: Think of the organoid as a tiny water balloon. If the "pipes" (channels) inside the balloon work, water rushes in, and the balloon swells up.
  • The Result: When they added the chemical, the dog organoids swelled up. This proved that their "pipes" (specifically the CFTR channels, which are crucial for fluid balance) were working perfectly. It meant the mini-guts were alive and doing their job.

4. Why Does This Matter?

Before this study, trying to grow dog gut cells in a lab was like trying to bake a cake without a recipe—you might get something, but it wouldn't be reliable.

Now, the scientists have a recipe.

• For Dog Owners: This means we can better study and treat diseases like IBD or colon cancer in dogs.
• For Humans: Because dog guts are so similar to human guts, this model can help us test new drugs for human diseases before we ever give them to people. It's a "One Health" win—helping both species at the same time.

The Bottom Line

The scientists successfully built a working model of a dog's intestine in a dish. They found the perfect amount of "fertilizer" (PGE2) to make them grow and a two-step training program to teach them how to act like real gut cells. While they only tested two dogs (so they need to test more to be 100% sure), they proved that this "mini-gut" is alive, healthy, and functional. It's a giant leap forward for veterinary science and medical research.

Technical Summary

1. Problem Statement

While intestinal organoid technology is well-established for humans and mice, canine intestinal organoids remain underexplored. Dogs are valuable translational models for gastrointestinal diseases (e.g., Inflammatory Bowel Disease, colorectal cancer) due to shared clinical and pathological features with humans. However, existing canine organoid protocols face several challenges:

• Limited Differentiation: Standard expansion media often favor stem cell maintenance over the differentiation into specialized secretory and absorptive cell types.
• Unclear Niche Composition: The specific cellular mechanisms and niche factors supporting intestinal stem cells in dogs are not fully defined (e.g., the presence of classical Paneth cells is debated).
• Lack of Optimized Protocols: There is a need for standardized, optimized methods for the long-term expansion and directed differentiation of organoids from specific canine intestinal segments (duodenum and colon).

2. Methodology

The study utilized a two-phase approach: Isolation/Expansion and Differentiation, utilizing tissues from two healthy canine cadavers (one male, one female) collected <12 hours post-mortem.

A. Isolation and Culture

• Source: Duodenal and colonic tissues were dissected, washed, and treated with EDTA to release crypts.
• Matrix: Crypts were embedded in Matrigel (3D culture).
• Expansion Medium (EM): Based on standard EGF/Noggin/R-spondin cocktails but optimized with Prostaglandin E₂ (PGE₂) at varying concentrations (0, 10 nM, 100 nM) to test growth effects.
• Passaging: Organoids were passaged every 7 days (1:4 ratio) using enzymatic dissociation (TrypLE) up to Passage 12 (P12).

B. Differentiation Protocol

A two-step differentiation strategy was implemented at Passages 3 (P3) and 6 (P6):

1. Patterning Medium (PM): Applied for 7 days to transition cells from proliferation to early differentiation.
2. Differentiation Medium (DM): Applied for an additional 7 days to promote lineage maturation.
   • Duodenum-specific DM: Included IL-22 (to support Paneth-like cell differentiation) and CHIR99021 (GSK-3 inhibitor to modulate Wnt signaling).
   • Colon-specific DM: Varied slightly in composition compared to the duodenum.

C. Analytical Techniques

• qRT-PCR: Quantified expression of intestinal markers: VIL1 (enterocytes), SI (sucrase-isomaltase), LGR5 (stem cells), CHGA (enteroendocrine), and MUC2 (goblet cells). Normalized against reference genes (RPL13, RPS19, B2M).
• Immunohistochemistry (IHC): Confocal microscopy used to visualize protein localization of Villin-1, FABP2, E-cadherin, and Ki-67 (proliferation marker).
• Functional Assay: Forskolin-induced swelling assay to test Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) activity. Organoids were exposed to 2.5, 5, and 10 µM forskolin, and swelling was measured over 3 hours.
• Cryopreservation: Organoids were successfully frozen and recovered using recovery cell freezing media.

3. Key Contributions

• Optimization of PGE₂: Identified 100 nM PGE₂ as the optimal concentration for the expansion medium, significantly enhancing crypt budding and organoid-forming efficiency compared to lower concentrations or no PGE₂.
• Segment-Specific Differentiation: Established a two-phase (PM/DM) protocol that successfully drives canine duodenal and colonic organoids toward differentiation while maintaining tissue-specific gene expression patterns.
• Functional Validation: Demonstrated that canine organoids possess functional CFTR channels, evidenced by dose- and time-dependent swelling upon forskolin stimulation.
• Resource Creation: Successfully established a cryopreserved bank of canine duodenal and colonic organoids, enabling future longitudinal studies.

4. Results

• Growth: Organoids cultured with 100 nM PGE₂ showed superior growth and proliferation compared to controls.
• Gene Expression Trends:
  • Duodenum: Markers (VIL1, SI, CHGA, MUC2, LGR5) generally showed higher expression in Patterning Medium (PM) compared to Differentiation Medium (DM), suggesting PM may effectively balance stemness and early differentiation.
  • Colon: Absorptive markers (VIL1, SI) and CHGA were higher in DM, while MUC2 remained higher in PM.
  • Statistical Note: Due to the small sample size (n=2 donors), no statistically significant differences were found (p > 0.05), but consistent biological trends were observed.
• Protein Expression: IHC confirmed the presence of absorptive (VIL1, FABP2) and structural (E-cadherin) markers in both EM and DM. Notably, Ki-67 (proliferation) was reduced in DM, indicating a shift toward a differentiated state.
• Functionality: Forskolin induced significant, dose-dependent swelling in both duodenal and colonic organoids, confirming active CFTR-mediated ion transport.
• Viability: Organoids were successfully maintained to P12 and cryopreserved with high recovery rates.

5. Significance and Limitations

Significance:

• Translational Model: Provides a robust in vitro model for studying canine gastrointestinal diseases (IBD, cancer) and testing therapeutics, bridging the gap between murine models and human clinical trials.
• One Health: Supports comparative medicine by validating a model that shares pathology with humans but offers fewer ethical constraints than human trials.
• Protocol Standardization: Offers a refined, step-by-step protocol for isolating, expanding, and differentiating canine organoids, addressing previous gaps in the field.

Limitations:

• Sample Size: The study relied on only two dogs (one duodenum, one colon). This limits statistical power and generalizability.
• Paneth Cell Uncertainty: While IL-22 was added to induce Paneth-like cells, the study did not definitively confirm the presence of classical Paneth cells in dogs, as their existence in the canine intestine remains a subject of debate.
• Differentiation Depth: While markers were expressed, the study notes that further optimization is needed to achieve full functional maturation of all cell lineages.

Conclusion:
This study successfully establishes a foundational protocol for canine intestinal organoids. By optimizing PGE₂ concentrations and implementing a two-phase differentiation strategy, the authors created a functional, expandable, and cryopreservable model. Despite sample size constraints, the results validate the model's physiological relevance, paving the way for future disease modeling and drug discovery in veterinary and comparative medicine.